Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000214082

Medchemexpress LLC 4-((3,5-dichloro-2-hydroxybenzyl)amino)-2-hydroxybenzoic acid | 1181226-02-7 | 99.2% | 328.15 g/mol | C14H11Cl2NO4 | 25 MG
SDP

Supplier:  Medchemexpress LLC HY10045625MG

Encompass_Preferred

ZL006 is a small-molecule research inhibitor that disrupts the interaction between neuronal nitric oxide synthase (nNOS) and postsynaptic density protein-95 (PSD-95), reducing NMDA receptor-mediated nitric oxide (NO) production. It is used in preclinical studies to evaluate neuroprotection and modulation of excitotoxic signaling.

  • Selective disruption of nNOS-PSD-95 interaction.
  • Reduces NMDA receptor-mediated nitric oxide synthesis.
  • Demonstrated neuroprotective activity in preclinical models.
  • High chemical purity suitable for research applications.
  • Suitable for in vitro and in vivo preclinical studies.

Catalog No. 50-002-14082


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.